ALEMBIC PHARMA at All Time High; BSE HEALTHCARE Index Up 0.3%
May 22, 2020 09:45 AM

ALEMBIC PHARMA share price has hit an all-time high at Rs 913 (up 1.1%).

Meanwhile, the BSE HEALTHCARE Index is at 15,520 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE Index today are ALEMBIC PHARMA (up 1.1%) and ABBOTT INDIA (up 1.2%).

DIVIS LABORATORIES (down 0.1%) and J.B.CHEMICALS (down 0.2%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 530 to Rs 913, registering a gain of Rs 383 (up 71.3%).

The BSE HEALTHCARE has moved up from 13,260 to 15,520, registering a gain of 2,260 points (up 16.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 121.0%), J.B.CHEMICALS (up 93.1%) and IPCA LABS (up 75.8%).

What About the Benchmark Indices?

The BSE Sensex is at 31,005 . The top gainers among the BSE Sensex stocks today are INFOSYS (up 1.7%), SBI (up 1.7%) and ULTRATECH CEMENT (up 1.4%). Other gainers include TECH MAHINDRA (up 1.1%) and RELIANCE IND. (up 0.9%). The most traded stocks in the BSE Sensex are SBI and INDUSIND BANK.

In the meantime, NSE Nifty is at 9,121 . The top gainers in the NSE Nifty include ZEE ENTERTAINMENT (up 4.8%), ULTRATECH CEMENT (up 1.7%) and SBI (up 1.7%). Other gainers include INFOSYS (up 1.4%) and UPL (up 1.3%).

Over the last 12 months, the BSE Sensex has moved down from 38,970 to 31,005, registering a loss of -7,965 points (up -20.6%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit stood at Rs 2 billion for the quarter ended December 2019, compared to a profit of Rs 2 billion a year ago. Net Sales rose 18.8% to Rs 12.1 billion during the period as against Rs 10.2 billion in October-December 2018.

For the year ended March 2019, ALEMBIC PHARMA reported 40.8% increase in net profit to Rs 5.9 billion compared to net profit of Rs 4.2 billion during FY18.

Revenue of the company grew 25.7% to Rs 39 billion during FY19.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 23.3x.